TRCT
APVO icon

Tower Research Capital (TRC)’s Aptevo Therapeutics APVO Stock Holding History

Tower Research Capital (TRC)’s Portfolio APVO Stock Details APVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-92
Closed -$868 – 5109
2025
Q4 		$868 Buy
92
+12
+15% +$285 ﹤0.01% 4802
2025
Q3 		$2.1K Buy
80
+14
+21% +$562 ﹤0.01% 4684
2025
Q2 		$3.64K Buy
66
+57
+633% +$10.4K ﹤0.01% 4462
2025
Q1 		$3.78K Buy
9
+6
+200% +$7.59K ﹤0.01% 4353
2024
Q4 		$4.68K Buy
3
+1
+50% +$2.88K ﹤0.01% 4414
2024
Q3 		$4.51K Buy
2
+1
+100% +$4.6K ﹤0.01% 4517
2024
Q2 		$2.37K Buy
+1
New +$14.9K ﹤0.01% 5011
2024
Q1 		– Hold
0
– – – 4410
2023
Q4 		– Hold
0
– – – 5213
2023
Q3 		– Hold
0
– – – 4862
2023
Q2 		– Hold
0
– – – 5234
2023
Q1 		– Hold
0
– – – 5777
2022
Q4 		– Hold
0
– – – 5855
2022
Q3 		– Hold
0
– – – 4632
2021
Q4 		– Hold
0
– -$18K – 6112
2021
Q3 		– Hold
0
– – – 3801
2021
Q2 		– Hold
0
– -$4K – 5445
2021
Q1 		– Hold
0
– – – 4753
2020
Q4 		– Hold
0
– – – 4364
2020
Q3 		– Hold
0
– -$20K – 4805
2020
Q2 		– Hold
0
– – – 3669
2020
Q1 		– Hold
0
– – – 2722
2019
Q1 		– Hold
0
– -$5K – 3758
2018
Q4 		– Hold
0
– – – 2877
2018
Q3 		– Hold
0
– – – 3550
2018
Q2 		– Hold
0
– – – 2615
2018
Q1 		– Hold
0
– – – 3042
2017
Q4 		– Hold
0
– – – 2791
2017
Q3 		– Hold
0
– -$5K – 3758
2017
Q2 		– Hold
0
– – – 1964
2017
Q1 		– Hold
0
– – – 1749
2016
Q4 		– Hold
0
– – – 3558

Other funds holding APVO

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Tower Research Capital (TRC)'s APVO Position: Q1 2026 in Review

Tower Research Capital (TRC) sold out of Aptevo Therapeutics (APVO) in Q1 2026, closing a stake of 92 shares — an estimated $868 sold.

Tower Research Capital (TRC) first reported a position in APVO in Q2 2024 and held it in 7 quarters. The position peaked at $4.68K in Q4 2024. 9 funds tracked by Wall St. Rank hold APVO as of Q1 2026.

  • Tower Research Capital (TRC) reported no remaining Aptevo Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 92 Aptevo Therapeutics shares in Q1 2026, an estimated $868.
  • Tower Research Capital (TRC) first reported a position in Aptevo Therapeutics in Q2 2024 and held it in 7 quarters.
  • Tower Research Capital (TRC)'s Aptevo Therapeutics position peaked at $4.68K in Q4 2024.
  • 9 funds tracked by Wall St. Rank held Aptevo Therapeutics as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.